Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion

Ann Thorac Surg. 2004 Jun;77(6):2213-5. doi: 10.1016/S0003-4975(03)01423-1.

Abstract

Postoperative chylothorax compromises nutrition, immune function, coagulation, and fluid status. We report rapid short-term suppression of chylothorax by octreotide in an infant after surgery for complex congenital heart disease complicated by lymphangiectasia.

Publication types

  • Case Reports

MeSH terms

  • Chylothorax / drug therapy*
  • Chylothorax / etiology
  • Drainage
  • Heart Defects, Congenital / surgery
  • Humans
  • Infant, Newborn
  • Infusions, Intravenous
  • Lymphangiectasis / complications
  • Lymphangiectasis / congenital*
  • Octreotide / administration & dosage*
  • Postoperative Complications*

Substances

  • Octreotide